Xu Lu

509 total citations
10 papers, 371 citations indexed

About

Xu Lu is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Xu Lu has authored 10 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Physiology and 3 papers in Cancer Research. Recurrent topics in Xu Lu's work include Cancer-related molecular mechanisms research (3 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Xu Lu is often cited by papers focused on Cancer-related molecular mechanisms research (3 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Xu Lu collaborates with scholars based in China and United States. Xu Lu's co-authors include Lun–Xiu Qin, Qiongzhu Dong, Qing‐Hai Ye, Xiao-Fei Zhang, Lei Liang, Xin Yang, Hu‐Liang Jia, Wenlong Zhai, Yilei Deng and Renfeng Li and has published in prestigious journals such as Hepatology, Clinical Nutrition and International Immunopharmacology.

In The Last Decade

Xu Lu

10 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xu Lu China	9	271	209	56	52	43	10	371
Shi-Zhe Zhang China	6	215 0.8×	190 0.9×	39 0.7×	22 0.4×	49 1.1×	8	319
Timothy A. Dinh United States	9	205 0.8×	133 0.6×	53 0.9×	81 1.6×	46 1.1×	15	307
Yimin Xiong China	10	248 0.9×	153 0.7×	40 0.7×	24 0.5×	59 1.4×	16	375
Fuchao Ma China	13	319 1.2×	223 1.1×	32 0.6×	23 0.4×	60 1.4×	25	407
Liangtao Ye Germany	8	186 0.7×	173 0.8×	40 0.7×	48 0.9×	84 2.0×	18	342
Yirui Yin China	11	206 0.8×	136 0.7×	25 0.4×	41 0.8×	78 1.8×	23	343
Zhixiang Jian China	9	201 0.7×	189 0.9×	47 0.8×	23 0.4×	94 2.2×	12	334
Everardo Macias United States	9	155 0.6×	150 0.7×	87 1.6×	28 0.5×	71 1.7×	15	331
Jingxiong Hu China	5	311 1.1×	220 1.1×	23 0.4×	27 0.5×	28 0.7×	6	411
Zheng Dang China	8	263 1.0×	190 0.9×	24 0.4×	27 0.5×	84 2.0×	9	343

Countries citing papers authored by Xu Lu

Since Specialization

Citations

This map shows the geographic impact of Xu Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Lu more than expected).

Fields of papers citing papers by Xu Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Lu. The network helps show where Xu Lu may publish in the future.

Co-authorship network of co-authors of Xu Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Lu. A scholar is included among the top collaborators of Xu Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Lu. Xu Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Xu, Chao, Lei Zhang, Ziwei Wang, et al.. (2022). Faeces from malnourished colorectal cancer patients accelerate cancer progression. Clinical Nutrition. 41(3). 632–644. 13 indexed citations

2.

Zhu, Pengfei, Ruo Feng, Xu Lu, et al.. (2021). Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma. Aging. 13(3). 4138–4156. 20 indexed citations

3.

Lu, Xu, Chao Yang, Yuanchang Hu, et al.. (2020). Upregulation of miR-1254 promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion via Inactivation of the Hippo-YAP signaling pathway by decreasing PAX5. Journal of Cancer. 12(3). 771–789. 16 indexed citations

4.

Shi, Chengyu, Qi Wang, Zhuqing Rao, et al.. (2020). Diabetes induces hepatocyte pyroptosis by promoting oxidative stress-mediated NLRP3 inflammasome activation during liver ischaemia and reperfusion injury. Annals of Translational Medicine. 8(12). 739–739. 30 indexed citations

5.

Wu, Xiao, Rong Xue, Hao Peng, et al.. (2019). Traf6 inhibitor boosts antitumor immunity by impeding regulatory T cell migration in Hepa1-6 tumor model. International Immunopharmacology. 77. 105965–105965. 11 indexed citations

6.

Dai, Xinzheng, Xu Lu, Xuehao Wang, et al.. (2018). Preoperative short-term fasting protects liver injury in patients undergoing hepatectomy. Annals of Translational Medicine. 6(23). 449–449. 11 indexed citations

7.

Lu, Xu, et al.. (2017). Long Noncoding RNA AFAP1-AS1 Promoted Tumor Growth and Invasion in Cholangiocarcinoma. Cellular Physiology and Biochemistry. 42(1). 222–230. 58 indexed citations

8.

Deng, Yilei, et al.. (2016). A multidrug cocktail approach attenuates ischemic-type biliary lesions in liver transplantation from non-heart-beating donors. Medical Hypotheses. 91. 47–52. 3 indexed citations

9.

Wang, Zheng, Yuan‐Yuan Sheng, Xiaomei Gao, et al.. (2015). β-catenin mutation is correlated with a favorable prognosis in patients with hepatocellular carcinoma. Molecular and Clinical Oncology. 3(4). 936–940. 39 indexed citations

10.

Yang, Xin, Xiao-Fei Zhang, Xu Lu, et al.. (2013). MicroRNA-26a Suppresses Angiogenesis in Human Hepatocellular Carcinoma by Targeting Hepatocyte Growth Factor-cMet Pathway. Hepatology. 59(5). 1874–1885. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact